Intuitive Surgical (IUI1) Stock Forecast & Price Target

34 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IUI1 Analyst Ratings

Moderate Buy

14 Buy

4 Hold

1 Sell

Based on 19 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IUI1 Stock 12 Month Forecast

Average Price Target

€492.16

▲(23.16% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is €492.16 with a high forecast of €587.44 and a low forecast of €320.90. The average price target represents a 23.16% change from the last price of €399.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"319":"€319","588":"€588","386.25":"€386.3","453.5":"€453.5","520.75":"€520.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":587.4358866,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€587.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":492.16021544,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€492.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":320.89781268,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€320.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[319,386.25,453.5,520.75,588],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,355.7,373.52583743076923,391.35167486153847,409.1775122923077,427.0033497230769,444.8291871538462,462.6550245846154,480.4808620153846,498.30669944615386,516.132536876923,533.9583743076923,551.7842117384615,569.6100491692308,{"y":587.4358866,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,355.7,366.1969396492308,376.6938792984615,387.1908189476923,397.68775859692306,408.18469824615386,418.6816378953846,429.1785775446154,439.67551719384613,450.17245684307693,460.66939649230767,471.16633614153847,481.66327579076926,{"y":492.16021544,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,355.7,353.0229086676923,350.3458173353846,347.6687260030769,344.9916346707692,342.31454333846153,339.63745200615386,336.96036067384614,334.28326934153847,331.6061780092308,328.9290866769231,326.2519953446154,323.5749040123077,{"y":320.89781268,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":455.75,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":417.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":405,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":369.85,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":462.35,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":491,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":489.2,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.25,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":386.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":361.25,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€587.44

Average Price Target€492.16

Lowest Price Target€320.90

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Zimmerman

BTIG

€503.27

Buy

25.94%

Upside

Reiterated

06/22/26

BTIG Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

David Roman

Goldman Sachs

€489.24

Buy

22.43%

Upside

Reiterated

06/15/26

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (NASDAQ: BLTE), Climb Bio (NASDAQ: CLYM) and Intuitive Surgical (NASDAQ: ISRG)

Travis Steed

Bank of America Securities

€455.92→€451.54

Buy

13.00%

Upside

Reiterated

06/12/26

Intuitive Surgical price target lowered to $515 from $520 at BofAIntuitive Surgical price target lowered to $515 from $520 at BofA

Adam Maeder

Piper Sandler

€508.53

Buy

27.26%

Upside

Reiterated

06/02/26

Piper Sandler Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Imron Zafar

Deutsche Bank

€385.78→€320.9

Sell

-19.70%

Downside

Reiterated

06/02/26

Intuitive Surgical price target lowered to $366 from $440 at Deutsche BankIntuitive Surgical price target lowered to $366 from $440 at Deutsche Bank

Larry Biegelsen

Wells Fargo

€573.41

Buy

43.50%

Upside

Reiterated

05/28/26

Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

€517.29

Buy

29.45%

Upside

Reiterated

05/28/26

Citi Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Unknown Analyst

Erste Group

Not Ranked

Erste Group

―

Hold

―

Reiterated

05/05/26

Matt Miksic

Barclays

€624.26→€570.78

Buy

42.84%

Upside

Assigned

04/23/26

Intuitive Surgical price target lowered to $651 from $712 at BarclaysIntuitive Surgical price target lowered to $651 from $712 at Barclays

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€451.54

Hold

13.00%

Upside

Reiterated

04/22/26

Jefferies Sticks to Their Hold Rating for Intuitive Surgical (ISRG)

Richard Newitter

Truist Financial

€508.53

Buy

27.26%

Upside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Quest Diagnostics (NYSE: DGX) and Merck & Company (NYSE: MRK)

Robbie Marcus

J.P. Morgan

€482.22

Buy

20.68%

Upside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), Danaher (NYSE: DHR) and Intuitive Surgical (NASDAQ: ISRG)

Mathew Blackman

TD Cowen

€578.67→€512.91

Buy

28.36%

Upside

Reiterated

04/22/26

Intuitive Surgical: Strong Q1 Execution, Rising DV5 Utilization, and Manageable International Headwinds Support Buy Rating

David Rescott

Robert W. Baird

€504.14→€534.83

Buy

33.84%

Upside

Reiterated

04/22/26

Intuitive Surgical price target raised to $610 from $575 at BairdIntuitive Surgical price target raised to $610 from $575 at Baird

Rick Wise

Stifel Nicolaus

€587.44

Buy

47.01%

Upside

Reiterated

04/22/26

Intuitive Surgical (ISRG) Gets a Buy from Stifel Nicolaus

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Zimmerman

BTIG

€503.27

Buy

25.94%

Upside

Reiterated

06/22/26

BTIG Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

David Roman

Goldman Sachs

€489.24

Buy

22.43%

Upside

Reiterated

06/15/26

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (NASDAQ: BLTE), Climb Bio (NASDAQ: CLYM) and Intuitive Surgical (NASDAQ: ISRG)

Travis Steed

Bank of America Securities

€455.92→€451.54

Buy

13.00%

Upside

Reiterated

06/12/26

Intuitive Surgical price target lowered to $515 from $520 at BofAIntuitive Surgical price target lowered to $515 from $520 at BofA

Adam Maeder

Piper Sandler

€508.53

Buy

27.26%

Upside

Reiterated

06/02/26

Piper Sandler Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Imron Zafar

Deutsche Bank

€385.78→€320.9

Sell

-19.70%

Downside

Reiterated

06/02/26

Intuitive Surgical price target lowered to $366 from $440 at Deutsche BankIntuitive Surgical price target lowered to $366 from $440 at Deutsche Bank

Larry Biegelsen

Wells Fargo

€573.41

Buy

43.50%

Upside

Reiterated

05/28/26

Wells Fargo Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)

Joanne Wuensch

Citi

€517.29

Buy

29.45%

Upside

Reiterated

05/28/26

Citi Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Unknown Analyst

Erste Group

Not Ranked

Erste Group

―

Hold

―

Reiterated

05/05/26

Matt Miksic

Barclays

€624.26→€570.78

Buy

42.84%

Upside

Assigned

04/23/26

Intuitive Surgical price target lowered to $651 from $712 at BarclaysIntuitive Surgical price target lowered to $651 from $712 at Barclays

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€451.54

Hold

13.00%

Upside

Reiterated

04/22/26

Jefferies Sticks to Their Hold Rating for Intuitive Surgical (ISRG)

Richard Newitter

Truist Financial

€508.53

Buy

27.26%

Upside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (NASDAQ: ISRG), Quest Diagnostics (NYSE: DGX) and Merck & Company (NYSE: MRK)

Robbie Marcus

J.P. Morgan

€482.22

Buy

20.68%

Upside

Reiterated

04/22/26

Analysts Offer Insights on Healthcare Companies: Rapport Therapeutics, Inc. (NASDAQ: RAPP), Danaher (NYSE: DHR) and Intuitive Surgical (NASDAQ: ISRG)

Mathew Blackman

TD Cowen

€578.67→€512.91

Buy

28.36%

Upside

Reiterated

04/22/26

Intuitive Surgical: Strong Q1 Execution, Rising DV5 Utilization, and Manageable International Headwinds Support Buy Rating

David Rescott

Robert W. Baird

€504.14→€534.83

Buy

33.84%

Upside

Reiterated

04/22/26

Intuitive Surgical price target raised to $610 from $575 at BairdIntuitive Surgical price target raised to $610 from $575 at Baird

Rick Wise

Stifel Nicolaus

€587.44

Buy

47.01%

Upside

Reiterated

04/22/26

Intuitive Surgical (ISRG) Gets a Buy from Stifel Nicolaus

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

3 Months

Rick WiseStifel Nicolaus

Success Rate

21/29 ratings generated profit

Average Return

+7.30%

Copying Rick Wise's trades and holding each position for 3 Months would result in 72.41% of your transactions generating a profit, with an average return of +7.30% per trade.

1 Year

Joanne WuenschCiti

Success Rate

19/25 ratings generated profit

Average Return

+22.04%

Copying Joanne Wuensch's trades and holding each position for 1 Year would result in 76.00% of your transactions generating a profit, with an average return of +22.04% per trade.

2 Years

Joanne WuenschCiti

Success Rate

21/25 ratings generated profit

Average Return

+41.98%

Copying Joanne Wuensch's trades and holding each position for 2 Years would result in 84.00% of your transactions generating a profit, with an average return of +41.98% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IUI1 Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IUI1 has received 11 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. IUI1 average Analyst price target in the past 3 months is 492.16.

Each month's total comprises the sum of three months' worth of ratings.

IUI1 Financial Forecast

IUI1 Earnings Forecast

Next quarter’s earnings estimate for IUI1 is €2.21 with a range of €2.12 to €2.38. The previous quarter’s EPS was €2.20. IUI1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IUI1 has Performed in-line its overall industry.

IUI1 Sales Forecast

Next quarter’s sales forecast for IUI1 is €2.48B with a range of €2.44B to €2.53B. The previous quarter’s sales results were €2.43B. IUI1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IUI1 has Performed in-line its overall industry.

IUI1 Stock Forecast FAQ

What is DE:IUI1’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 492.16.

What is DE:IUI1’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 23.16% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Intuitive Surgical a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 4 hold ratings and 1 sell ratings.

What is Intuitive Surgical’s share price target?

The average share price target for Intuitive Surgical is 492.16. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €587.44 ,and the lowest forecast is €320.90. The average share price target represents 23.16% Increase from the current price of €399.6.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of Intuitive Surgical?

To buy shares of DE:IUI1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Intuitive Surgical (IUI1) Stock Forecast & Price Target

IUI1 Analyst Ratings

IUI1 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

IUI1 Analyst Recommendation Trends

IUI1 Financial Forecast

IUI1 Earnings Forecast

IUI1 Sales Forecast

IUI1 Stock Forecast FAQ

Detailed List of Analyst Forecasts